Research Overview

Michael Landzberg's major research interests relate to understanding congenital heart disease as it displays itself in the adult patient, with particular focus on three areas--pulmonary hypertension and vascular disease, heart failure/mechanics, and the role of interventional catheterization.

 

Research Background

Michael Landzberg received his MD from Harvard Medical School. He completed an internship and residency at Columbia University and a fellowship at Brigham and Women's Hospital.

 

Education

Undergraduate School

Columbia University
1981 New York NY

Medical School

Harvard Medical School
1985 Boston MA

Internship

Columbia University
1988 New York NY

Residency

Columbia University
1989 New York NY

Fellowship

Brigham and Women's Hospital
1992 Boston MA

Media

Caregiver Profile

Meet Dr. Michael Landzberg

Publications

  1. The burden of psychological trauma and post-traumatic stress disorder among adults with congenital heart disease: PTSD in ACHD. Am J Cardiol. 2024 05 15; 219:9-16. View Abstract
  2. Palliative Care in Adult Congenital Heart Disease-Associated Advanced Heart Disease. Heart Fail Clin. 2024 Apr; 20(2):237-243. View Abstract
  3. Corrigendum to 'The role of sensitization in post-transplant outcomes in adults with congenital heart disease sensitization in adults with congenital heart disease', Int. J. Cardiol. Congenit. Heart Dis., 8, June 2022, 100384. Int J Cardiol Congenit Heart Dis. 2023 Dec; 14:100474. View Abstract
  4. Timely PAH Identification in Adults With Repaired Congenital Heart Disease? The ACHD-QuERI Registry Insights. JACC Adv. 2023 Nov; 2(9):100649. View Abstract
  5. Feasibility of frailty screening among patients with advanced heart failure. BMJ Open Qual. 2023 10; 12(4). View Abstract
  6. Top Ten Tips Palliative Care Clinicians Should Know About Delivering Specialty-Aligned Palliative Care. J Palliat Med. 2023 10; 26(10):1401-1407. View Abstract
  7. Specialty-Aligned Palliative Care: Responding to the Needs of a Tertiary Care Health System. J Pain Symptom Manage. 2022 12; 64(6):e341-e346. View Abstract
  8. The role of sensitization in post-transplant outcomes in adults with congenital heart disease sensitization in adults with congenital heart disease. Int J Cardiol Congenit Heart Dis. 2022 Jun; 8:100384. View Abstract
  9. The Association of Lower Venous Disease to Outcomes in Adults With Fontan Physiology: CALF Revisited. JACC Adv. 2022 Mar; 1(1):100002. View Abstract
  10. Top Ten Tips Palliative Care Clinicians Should Know About Solid Organ Transplantation. J Palliat Med. 2022 07; 25(7):1136-1142. View Abstract
  11. Serial cardiac biomarker assessment in adults with congenital heart disease hospitalized for decompensated heart failure?. Int J Cardiol Congenit Heart Dis. 2022 Mar; 7. View Abstract
  12. Tuning and external validation of an adult congenital heart disease risk prediction model. Eur Heart J Qual Care Clin Outcomes. 2022 01 05; 8(1):70-78. View Abstract
  13. Management of acute cardiovascular complications in pregnancy. Eur Heart J. 2021 11 01; 42(41):4224-4240. View Abstract
  14. Associations Between Clinical Outcomes and a Recently Proposed Adult Congenital Heart Disease Anatomic and Physiological Classification System. J Am Heart Assoc. 2021 09 21; 10(18):e021345. View Abstract
  15. Long-Term Fate of the Truncal Valve. J Am Heart Assoc. 2020 11 17; 9(22):e019104. View Abstract
  16. Interobserver agreement of the anatomic and physiological classification system for adult congenital heart disease. Am Heart J. 2020 11; 229:92-99. View Abstract
  17. Advanced Heart Failure Therapies for Adults With Congenital Heart Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 11 05; 74(18):2295-2312. View Abstract
  18. Reducing radiation dose from myocardial perfusion imaging in subjects with complex congenital heart disease. J Nucl Cardiol. 2021 08; 28(4):1395-1408. View Abstract
  19. Standardized outcomes in reproductive cardiovascular care: The STORCC initiative. Am Heart J. 2019 11; 217:112-120. View Abstract
  20. Knowledge of Life-Long Cardiac Care by Adolescents and Young Adults with Congenital Heart Disease. Pediatr Cardiol. 2019 Oct; 40(7):1439-1444. View Abstract
  21. Planned vaginal delivery and cardiovascular morbidity in pregnant women with heart disease. Am J Obstet Gynecol. 2020 01; 222(1):77.e1-77.e11. View Abstract
  22. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 04 02; 139(14):e698-e800. View Abstract
  23. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 04 02; 139(14):e637-e697. View Abstract
  24. Evaluation of Macitentan in Patients With Eisenmenger Syndrome. Circulation. 2019 01 02; 139(1):51-63. View Abstract
  25. Prospective cohort study of C-reactive protein as a predictor of clinical events in adults with congenital heart disease: results of the Boston adult congenital heart disease biobank. Eur Heart J. 2018 09 07; 39(34):3253-3261. View Abstract
  26. Disparities in Wait-List Outcomes for Adults With Congenital Heart Disease Listed for Heart Transplantation Before and Since Revision of Status I Listing. Am J Cardiol. 2018 11 15; 122(10):1761-1764. View Abstract
  27. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 04 02; 73(12):e81-e192. View Abstract
  28. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 04 02; 73(12):1494-1563. View Abstract
  29. Relationship of Red Cell Distribution Width to Adverse Outcomes in Adults With Congenital Heart Disease (from the Boston Adult Congenital Heart Biobank). Am J Cardiol. 2018 11 01; 122(9):1557-1564. View Abstract
  30. A Pilot Study of Inspiratory Muscle Training to Improve Exercise Capacity in Patients with Fontan Physiology. Semin Thorac Cardiovasc Surg. 2018 Winter; 30(4):462-469. View Abstract
  31. Congenital tricuspid valve disease can masquerade as primary idiopathic tricuspid regurgitation. Heart. 2018 06; 104(11):959. View Abstract
  32. Transition Education: Formative Steps, in Need of Direction. J Am Coll Cardiol. 2018 04 24; 71(16):1778-1780. View Abstract
  33. Association of Albuminuria With Major Adverse Outcomes in Adults With Congenital Heart Disease: Results From the Boston Adult Congenital Heart Biobank. JAMA Cardiol. 2018 04 01; 3(4):308-316. View Abstract
  34. A Randomized Trial Comparing Cardiac Rehabilitation to Standard of Care for Adults With Congenital Heart Disease. World J Pediatr Congenit Heart Surg. 2018 03; 9(2):185-193. View Abstract
  35. Hemodynamic and metabolic characteristics associated with development of a right ventricular outflow tract pressure gradient during upright exercise. PLoS One. 2017; 12(6):e0179053. View Abstract
  36. Decline in peak oxygen consumption over time predicts death or transplantation in adults with a Fontan circulation. Am Heart J. 2017 Jul; 189:184-192. View Abstract
  37. Accuracy of Echocardiography to Estimate Pulmonary Artery Pressures With Exercise: A Simultaneous Invasive-Noninvasive Comparison. Circ Cardiovasc Imaging. 2017 Apr; 10(4). View Abstract
  38. Anomalous Aortic Origin of a Coronary Artery From the Inappropriate Sinus of Valsalva. J Am Coll Cardiol. 2017 Mar 28; 69(12):1592-1608. View Abstract
  39. Development of a Right Ventricular Outflow Tract Gradient During Upright Exercise: A Hemodynamic Observation. J Am Coll Cardiol. 2017 02 07; 69(5):595-597. View Abstract
  40. Predictors of Death in Contemporary Adult Patients With Eisenmenger Syndrome: A Multicenter Study. Circulation. 2017 Apr 11; 135(15):1432-1440. View Abstract
  41. Liver health in adults with Fontan circulation: A multicenter cross-sectional study. J Thorac Cardiovasc Surg. 2017 03; 153(3):656-664. View Abstract
  42. Design and Implementation of a Prospective Adult Congenital Heart Disease Biobank. World J Pediatr Congenit Heart Surg. 2016 11; 7(6):734-743. View Abstract
  43. Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation. Heart. 2017 03; 103(6):434-442. View Abstract
  44. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients. J Heart Lung Transplant. 2017 Feb; 36(2):211-219. View Abstract
  45. Emerging Research Directions in Adult Congenital Heart Disease: A Report From an NHLBI/ACHA Working Group. J Am Coll Cardiol. 2016 Apr 26; 67(16):1956-64. View Abstract
  46. Anomalous origin of the coronary artery arising from the opposite sinus: prevalence and outcomes in patients undergoing coronary CTA. Eur Heart J Cardiovasc Imaging. 2017 Feb; 18(2):224-235. View Abstract
  47. Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation. J Am Heart Assoc. 2016 Jan 11; 5(1). View Abstract
  48. Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge. J Heart Lung Transplant. 2016 Feb; 35(2):151-64. View Abstract
  49. Transcatheter Therapies for the Treatment of Valvular and Paravalvular Regurgitation in Acquired and Congenital Valvular Heart Disease. J Am Coll Cardiol. 2015 Jul 14; 66(2):169-83. View Abstract
  50. Clinical applications of radionuclide imaging in the evaluation and management of patients with congenital heart disease. J Nucl Cardiol. 2016 Feb; 23(1):45-63. View Abstract
  51. Survival of adults with ASD2: a call for a longitudinal clinical registry. Eur Heart J. 2015 Aug 14; 36(31):2036-2038. View Abstract
  52. Structural heart disease: tetralogy, transposition, and truncus, too? J Am Coll Cardiol. 2015 May 26; 65(20):2260-1. View Abstract
  53. Implementation of the American College of Cardiology/American Heart Association 2008 Guidelines for the Management of Adults With Congenital Heart Disease. Am J Cardiol. 2015 Aug 01; 116(3):452-7. View Abstract
  54. The care of adults with congenital heart disease across the globe: Current assessment and future perspective: A position statement from the International Society for Adult Congenital Heart Disease (ISACHD). Int J Cardiol. 2015 Sep 15; 195:326-33. View Abstract
  55. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes. J Heart Lung Transplant. 2015 Jul; 34(7):883-91. View Abstract
  56. Tricuspid valve regurgitation in congenitally corrected transposition of the great arteries and a left ventricle to pulmonary artery conduit. Ann Thorac Surg. 2015 Apr; 99(4):1348-56. View Abstract
  57. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease. J Clin Endocrinol Metab. 2015 Apr; 100(4):1325-34. View Abstract
  58. Exercise oscillatory ventilation in patients with Fontan physiology. Circ Heart Fail. 2015 Mar; 8(2):304-11. View Abstract
  59. The impact of IMPACT: a game changer for congenital cardiology. J Am Coll Cardiol. 2014 Dec 16; 64(23):2452-4. View Abstract
  60. Impaired exercise capacity following atrial septal defect closure: an invasive study of the right heart and pulmonary circulation. Pulm Circ. 2014 Dec; 4(4):630-7. View Abstract
  61. [Updated clinical classification of pulmonary hypertension]. Turk Kardiyol Dern Ars. 2014 Oct; 42 Suppl 1:45-54. View Abstract
  62. Rare case of undiagnosed supracardiac total anomalous pulmonary venous return in an adult. Circulation. 2014 Sep 30; 130(14):1205-7. View Abstract
  63. Pulmonary arterial hypertension associated with congenital heart disease: recent advances and future directions. Int J Cardiol. 2014 Dec 15; 177(2):340-7. View Abstract
  64. MDCT of congenital coronary artery fistulas. AJR Am J Roentgenol. 2014 Sep; 203(3):W244-52. View Abstract
  65. Durability of large diameter right ventricular outflow tract conduits in adults with congenital heart disease. Int J Cardiol. 2014 Aug 20; 175(3):455-63. View Abstract
  66. Clinicians' perspectives on patient satisfaction in adult congenital heart disease clinics--a dimension of health care quality whose time has come. Congenit Heart Dis. 2015 Mar-Apr; 10(2):128-36. View Abstract
  67. Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses. Can J Cardiol. 2014 Oct; 30(10):1216-24. View Abstract
  68. Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity. Am J Physiol Heart Circ Physiol. 2014 Jul 01; 307(1):H110-7. View Abstract
  69. ACC/AHA/SCAI 2014 health policy statement on structured reporting for the cardiac catheterization laboratory: a report of the American College of Cardiology Clinical Quality Committee. Circulation. 2014 Jun 17; 129(24):2578-609. View Abstract
  70. ACC/AHA/SCAI 2014 health policy statement on structured reporting for the cardiac catheterization laboratory: a report of the American College of Cardiology Clinical Quality Committee. J Am Coll Cardiol. 2014 Jun 17; 63(23):2591-2623. View Abstract
  71. Specialized adult congenital heart care saves lives. Circulation. 2014 May 06; 129(18):1795-6. View Abstract
  72. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis. Congenit Heart Dis. 2014 Sep-Oct; 9(5):438-47. View Abstract
  73. Transition and transfer of adolescents and young adults with pediatric onset chronic disease: the patient and parent perspective. J Pediatr Rehabil Med. 2014; 7(1):43-51. View Abstract
  74. The exceptional and far-flung manifestations of heart failure in Eisenmenger syndrome. Heart Fail Clin. 2014 Jan; 10(1):91-104. View Abstract
  75. Evolving perspectives on heart failure in adults with congenital heart disease. Preface. Heart Fail Clin. 2014 Jan; 10(1):xv-xvi. View Abstract
  76. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013 Dec 24; 62(25 Suppl):D34-41. View Abstract
  77. Clinical research priorities in adult congenital heart disease. Int J Cardiol. 2014 Feb 15; 171(3):351-60. View Abstract
  78. Right heart failure: toward a common language. Pulm Circ. 2013 Dec; 3(4):963-7. View Abstract
  79. Towards widespread noninvasive assessment of pulmonary vascular resistance in clinical practice. J Am Soc Echocardiogr. 2014 Jan; 27(1):108-9. View Abstract
  80. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014 Feb; 100(3):247-53. View Abstract
  81. Right heart failure: toward a common language. J Heart Lung Transplant. 2014 Feb; 33(2):123-6. View Abstract
  82. Outcomes of adolescents and adults undergoing primary Fontan procedure. Am J Cardiol. 2013 Dec 15; 112(12):1938-42. View Abstract
  83. Physical activity is associated with improved aerobic exercise capacity over time in adults with congenital heart disease. Int J Cardiol. 2013 Oct 12; 168(5):4685-91. View Abstract
  84. Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation. Int J Cardiol. 2013 Oct 09; 168(4):3940-3. View Abstract
  85. Patent foramen ovale: when is intervention warranted? Can J Cardiol. 2013 Jul; 29(7):890-2. View Abstract
  86. Aortic valve dysfunction and aortic dilation in adults with coarctation of the aorta. Congenit Heart Dis. 2014 May-Jun; 9(3):235-43. View Abstract
  87. Bloodstream infections occurring in patients with percutaneously implanted bioprosthetic pulmonary valve: a single-center experience. Circ Cardiovasc Interv. 2013 Jun; 6(3):301-10. View Abstract
  88. A simple echocardiographic method to estimate pulmonary vascular resistance. Am J Cardiol. 2013 Sep 15; 112(6):873-82. View Abstract
  89. Improving heart disease knowledge and research participation in adults with congenital heart disease (the Health, Education and Access Research Trial: HEART-ACHD). Int J Cardiol. 2013 Oct 09; 168(4):3236-40. View Abstract
  90. Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept. Int J Cardiol. 2013 Oct 03; 168(3):2435-40. View Abstract
  91. Prevalence and predictors of gaps in care among adult congenital heart disease patients: HEART-ACHD (The Health, Education, and Access Research Trial). J Am Coll Cardiol. 2013 May 28; 61(21):2180-4. View Abstract
  92. The Changing Demographics of Congenital Heart Disease Hospitalizations in the United States, 1998 Through 2010. JAMA. 2013 Mar 13; 309(10):984-986. View Abstract
  93. Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience. J Heart Lung Transplant. 2013 Apr; 32(4):381-7. View Abstract
  94. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart. 2013 Apr; 99(7):491-6. View Abstract
  95. Adult congenital heart disease incidence and consultation: a survey of general adult cardiologists. J Am Coll Cardiol. 2013 Mar 26; 61(12):1303-4. View Abstract
  96. Left and right ventricular diastolic function in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Can J Cardiol. 2013 Jul; 29(7):866-72. View Abstract
  97. The effects of pregnancy on right ventricular remodeling in women with repaired tetralogy of Fallot. Int J Cardiol. 2013 Oct 03; 168(3):1847-52. View Abstract
  98. Adverse events rates and risk factors in adults undergoing cardiac catheterization at pediatric hospitals--results from the C3PO. Catheter Cardiovasc Interv. 2013 May; 81(6):997-1005. View Abstract
  99. Transcatheter closure of post-myocardial infarction ventricular septal rupture. Circ Cardiovasc Interv. 2013 Feb; 6(1):59-67. View Abstract
  100. Hospitalizations and mortality in the United States for adults with Down syndrome and congenital heart disease. Am J Cardiol. 2013 Apr 01; 111(7):1046-51. View Abstract
  101. Advance care planning and end-of-life management of adult patients with congenital heart disease. World J Pediatr Congenit Heart Surg. 2013 Jan; 4(1):62-9. View Abstract
  102. Lateral window sinus elevation technique: managing challenges and complications. J Can Dent Assoc. 2013; 79:d101. View Abstract
  103. Cardiovascular outcomes after the arterial switch operation for D-transposition of the great arteries. Circulation. 2013 Jan 22; 127(3):331-9. View Abstract
  104. Aortic root dilatation in adults with surgically repaired tetralogy of fallot: a multicenter cross-sectional study. Circulation. 2013 Jan 15; 127(2):172-9. View Abstract
  105. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a need for further dialogue, development, and collaborative study. Circ Cardiovasc Interv. 2012 Dec; 5(6):744-5. View Abstract
  106. Correlation of exercise response in repaired coarctation of the aorta to left ventricular mass and geometry. Am J Cardiol. 2013 Feb 01; 111(3):406-11. View Abstract
  107. A shifting approach to management of the thoracic aorta in bicuspid aortic valve. J Thorac Cardiovasc Surg. 2013 Aug; 146(2):339-46. View Abstract
  108. Referral patterns and perceived barriers to adult congenital heart disease care: results of a survey of U.S. pediatric cardiologists. J Am Coll Cardiol. 2012 Dec 11; 60(23):2411-8. View Abstract
  109. QRS duration and QRS fractionation on surface electrocardiogram are markers of right ventricular dysfunction and atrialization in patients with Ebstein anomaly. Eur Heart J. 2013 Jan; 34(3):191-200. View Abstract
  110. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study. Eur J Heart Fail. 2013 Mar; 15(3):277-83. View Abstract
  111. Multimodality imaging of a Gerbode defect. Circulation. 2012 Jul 03; 126(1):e1-2. View Abstract
  112. Single ventricle anatomy is associated with increased frequency of nonalcoholic cirrhosis. Int J Cardiol. 2013 Sep 01; 167(5):1918-23. View Abstract
  113. Rationale and design of an International Multicenter Registry of patients with repaired tetralogy of Fallot to define risk factors for late adverse outcomes: the INDICATOR cohort. Pediatr Cardiol. 2013 Jan; 34(1):95-104. View Abstract
  114. Acute dyspnea in a young man with an old sternotomy. Congenit Heart Dis. 2012 Sep-Oct; 7(5):E73-7. View Abstract
  115. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012 Mar 15; 366(11):991-9. View Abstract
  116. The Adult Congenital and Pediatric Cardiology Section: increasing the opportunities for the congenital heart disease community within the American College of Cardiology. J Am Coll Cardiol. 2012 Jan 03; 59(1):84-7. View Abstract
  117. Parental knowledge regarding lifelong congenital cardiac care. Pediatrics. 2011 Dec; 128(6):e1489-95. View Abstract
  118. Cerebral abscess due to persistent left superior vena cava draining into the left atrium. Circulation. 2011 Nov 22; 124(21):2362-4. View Abstract
  119. Resource use among adult congenital heart surgery admissions in pediatric hospitals: risk factors for high resource utilization and association with inpatient death. Circ Cardiovasc Qual Outcomes. 2011 Nov 01; 4(6):634-9. View Abstract
  120. Maternal cardiovascular events during childbirth among women with congenital heart disease. Heart. 2012 Jan; 98(2):145-51. View Abstract
  121. Pathophysiology of chronic venous insufficiency in adults with a Fontan circulation (a pre-defined substudy of the CALF investigation). Int J Cardiol. 2013 Apr 30; 165(1):41-5. View Abstract
  122. Risk factors for death after adult congenital heart surgery in pediatric hospitals. Circ Cardiovasc Qual Outcomes. 2011 Jul; 4(4):433-9. View Abstract
  123. A case series of the anesthetic management of parturients with surgically repaired tetralogy of Fallot. Anesth Analg. 2011 Aug; 113(2):307-17. View Abstract
  124. Exercise testing identifies patients at increased risk for morbidity and mortality following Fontan surgery. Congenit Heart Dis. 2011 Jul-Aug; 6(4):294-303. View Abstract
  125. Comparison of risk of hypertensive complications of pregnancy among women with versus without coarctation of the aorta. Am J Cardiol. 2011 May 15; 107(10):1529-34. View Abstract
  126. Pregnancy-related cardiac risk in women with congenital heart disease: is it over when it's over? Evid Based Med. 2011 Jun; 16(3):93-4. View Abstract
  127. Introduction: Adult congenital heart disease. Prog Cardiovasc Dis. 2011 Jan-Feb; 53(4):237-8. View Abstract
  128. Advances in transcatheter interventions in adults with congenital heart disease. Prog Cardiovasc Dis. 2011 Jan-Feb; 53(4):265-73. View Abstract
  129. Bicuspid aortic valve morphology. J Am Coll Cardiol. 2010 Nov 09; 56(20):1680; author reply 1680-1. View Abstract
  130. Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Stroke. 2010 Dec; 41(12):2872-83. View Abstract
  131. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010 Aug 31; 122(9):868-75. View Abstract
  132. Pregnancy outcomes in women with transposition of the great arteries and arterial switch operation. Am J Cardiol. 2010 Aug 01; 106(3):417-20. View Abstract
  133. The CALF (Congenital Heart Disease in Adults Lower Extremity Systemic Venous Health in Fontan Patients) study. J Am Coll Cardiol. 2010 Jul 06; 56(2):144-50. View Abstract
  134. Pregnancy in patients with tetralogy of fallot: invited commentary. World J Pediatr Congenit Heart Surg. 2010 Jul; 1(2):175-6. View Abstract
  135. A preliminary look at duplicate testing associated with lack of electronic health record interoperability for transferred patients. J Am Med Inform Assoc. 2010 May-Jun; 17(3):341-4. View Abstract
  136. Predictors of long-term adverse outcomes in patients with congenital coronary artery fistulae. Circ Cardiovasc Interv. 2010 Apr; 3(2):134-9. View Abstract
  137. Pregnant women with congenital heart disease: cardiac, anesthetic and obstetrical implications. Expert Rev Cardiovasc Ther. 2010 Mar; 8(3):439-48. View Abstract
  138. Lung abscess in adults with tetralogy of fallot and pulmonary atresia. Cardiol Young. 2010 Feb; 20(1):91-3. View Abstract
  139. Serial cardiopulmonary exercise testing in patients with previous Fontan surgery. Pediatr Cardiol. 2010 Feb; 31(2):175-80. View Abstract
  140. Atrial arrhythmias: a "call to arms" for congenital heart disease caregivers. Circulation. 2009 Oct 27; 120(17):1649-50. View Abstract
  141. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis. Int J Cardiol. 2010 Oct 29; 144(3):373-8. View Abstract
  142. Obstetric outcomes in pregnant women with congenital heart disease. Int J Cardiol. 2010 Oct 08; 144(2):195-9. View Abstract
  143. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events. Am Heart J. 2009 May; 157(5):867-74. View Abstract
  144. Not just big kids: closing atrial septal defects in adults older than 60 years. Circ Cardiovasc Interv. 2009 Apr; 2(2):83-4. View Abstract
  145. Recurrence of cerebrovascular events in young adults with a secundum atrial septal defect. Int J Cardiol. 2010 Jun 25; 142(1):44-9. View Abstract
  146. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 Dec 02; 52(23):e143-e263. View Abstract
  147. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation. 2008 Dec 02; 118(23):2395-451. View Abstract
  148. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation. 2008 Dec 02; 118(23):e714-833. View Abstract
  149. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol. 2008 Oct; 1(4):250-7. View Abstract
  150. Multicenter research in adult congenital heart disease. Int J Cardiol. 2008 Sep 26; 129(2):155-9. View Abstract
  151. Adult congenital heart disease: toward prospective risk assessment of a multisystemic condition. Circulation. 2008 May 06; 117(18):2311-2. View Abstract
  152. Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004. JAMA. 2008 Feb 06; 299(5):521-2. View Abstract
  153. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. 2008 Jan 22; 117(3):363-70. View Abstract
  154. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008 Jan 01; 117(1):85-92. View Abstract
  155. Transcatheter closure of high-risk muscular ventricular septal defects with the CardioSEAL occluder: initial report from the CardioSEAL VSD registry. Catheter Cardiovasc Interv. 2007 Nov 01; 70(5):740-4. View Abstract
  156. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study. Int J Cardiol. 2008 Jun 23; 127(1):27-32. View Abstract
  157. Pulmonary thrombectomy in a patient with hemoglobin Nottingham. Perfusion. 2007 Jul; 22(4):299-301. View Abstract
  158. Interventional catheterization in adult congenital heart disease. Circulation. 2007 Mar 27; 115(12):1622-33. View Abstract
  159. Congenital heart disease associated pulmonary arterial hypertension. Clin Chest Med. 2007 Mar; 28(1):243-53, x. View Abstract
  160. Acute and intermediate outcomes, and evaluation of injury to the aortic wall, as based on 15 years experience of implanting stents to treat aortic coarctation. Cardiol Young. 2007 Jun; 17(3):307-18. View Abstract
  161. Cardiac troponin increases among runners in the Boston Marathon. Ann Emerg Med. 2007 Feb; 49(2):137-43, 143.e1. View Abstract
  162. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart. 2008 Feb; 94(2):211-6. View Abstract
  163. Pregnancy outcomes after atrial repair for transposition of the great arteries. Am J Cardiol. 2006 Sep 01; 98(5):668-72. View Abstract
  164. Pulmonary arterial embolization of pacemaker lead electrode tip. Pacing Clin Electrophysiol. 2006 Jul; 29(7):784-7. View Abstract
  165. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006 Jul 04; 114(1):48-54. View Abstract
  166. Pediatric cardiology and adult congenital heart disease. J Am Coll Cardiol. 2006 Jun 06; 47(11 Suppl):D33-6. View Abstract
  167. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation. 2006 May 23; 113(20):2391-7. View Abstract
  168. Pregnancy outcomes in women with congenital heart disease. Circulation. 2006 Jan 31; 113(4):517-24. View Abstract
  169. Report of the National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease. J Am Coll Cardiol. 2006 Feb 21; 47(4):701-7. View Abstract
  170. Pediatric cardiology and congenital heart disease. J Am Coll Cardiol. 2005 Jun 07; 45(11 Suppl B):9B-11B. View Abstract
  171. Postinfarction ventricular septal defect with pseudoaneurysm repair after failed percutaneous closure. Ann Thorac Surg. 2005 Feb; 79(2):701-3. View Abstract
  172. Transitioning the young adult with congenital heart disease for life-long medical care. Pediatr Clin North Am. 2004 Dec; 51(6):1739-48, xi. View Abstract
  173. Transcatheter intracardiac device implantation for atrial level defects and thrombosis: a call for randomized, controlled data. J Am Coll Cardiol. 2004 Oct 19; 44(8):1713-4; author reply 1714-6. View Abstract
  174. Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension. Chest. 2004 Oct; 126(4):1255-61. View Abstract
  175. Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation. 2004 Aug 03; 110(5):501-7. View Abstract
  176. Long-term outcomes after the atrial switch for surgical correction of transposition: a meta-analysis comparing the Mustard and Senning procedures. Cardiol Young. 2004 Jun; 14(3):284-92. View Abstract
  177. Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation. 2004 Apr 27; 109(16):1994-2000. View Abstract
  178. Indications for the closure of patent foramen ovale. Heart. 2004 Feb; 90(2):219-24. View Abstract
  179. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med. 2003 Nov 04; 139(9):753-60. View Abstract
  180. Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology. Am J Cardiol. 2003 Mar 01; 91(5):632-5. View Abstract
  181. Depression and anxiety in adults with congenital heart disease: a pilot study. Heart Lung. 2003 Mar-Apr; 32(2):105-10. View Abstract
  182. Paradoxic cerebral embolism after cemented knee arthroplasty: a report of 2 cases and prophylactic option for subsequent arthroplasty. J Arthroplasty. 2003 Jan; 18(1):113-20. View Abstract
  183. Gadolinium-enhanced 3-dimensional magnetic resonance angiography of pulmonary blood supply in patients with complex pulmonary stenosis or atresia: comparison with x-ray angiography. Circulation. 2002 Jul 23; 106(4):473-8. View Abstract
  184. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002 Mar 21; 346(12):896-903. View Abstract
  185. Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension. Chest. 2001 Sep; 120(3):866-72. View Abstract
  186. Catheterization of the adult with congenital heart disease (ACHD): beyond "shooting the coronaries". J Interv Cardiol. 2001 Jun; 14(3):329-37. View Abstract
  187. Percutaneous coronary intervention and subsequent endovascular beta-radiation brachytherapy in a 14-year-old with repaired anomalous left coronary artery from pulmonary artery. J Invasive Cardiol. 2001 Jun; 13(6):494-500. View Abstract
  188. Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol. 2001 May; 37(6):1665-76. View Abstract
  189. Closure of atrial septal defects in adult patients: justification of the "tipping point". J Interv Cardiol. 2001 Apr; 14(2):267-9. View Abstract
  190. Task force 4: organization of delivery systems for adults with congenital heart disease. J Am Coll Cardiol. 2001 Apr; 37(5):1187-93. View Abstract
  191. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001 Jan 02; 103(1):10-3. View Abstract
  192. Accuracy of MRI evaluation of pulmonary blood supply in patients with complex pulmonary stenosis or atresia. Int J Card Imaging. 2000 Jun; 16(3):169-74. View Abstract
  193. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol. 2000 Apr; 35(5):1311-6. View Abstract
  194. Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension. Am J Obstet Gynecol. 1999 Apr; 180(4):1045-6. View Abstract
  195. In vivo evaluation of Fontan pathway flow dynamics by multidimensional phase-velocity magnetic resonance imaging. Circulation. 1998 Dec 22-29; 98(25):2873-82. View Abstract
  196. Transcatheter management of ventricular septal rupture after myocardial infarction. Semin Thorac Cardiovasc Surg. 1998 Apr; 10(2):128-32. View Abstract
  197. Isolated peripheral pulmonary artery stenoses in the adult. Circulation. 1996 Apr 01; 93(7):1417-23. View Abstract
  198. Long-term follow-up after surgical repair of ostium primum atrial septal defects in adults. J Am Coll Cardiol. 1996 Mar 01; 27(3):696-9. View Abstract
  199. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans. Circulation. 1996 Jan 15; 93(2):266-71. View Abstract
  200. Orthodeoxia-platypnea due to intracardiac shunting--relief with transcatheter double umbrella closure. Cathet Cardiovasc Diagn. 1995 Nov; 36(3):247-50. View Abstract
  201. Coronary artery abnormalities detected at cardiac catheterization following the arterial switch operation for transposition of the great arteries. Am J Cardiol. 1995 Jul 15; 76(3):153-7. View Abstract
  202. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol. 1995 Jun; 25(7):1656-64. View Abstract
  203. Balloon aortic valvuloplasty in the young adult with congenital aortic stenosis. Am J Cardiol. 1994 Jun 01; 73(15):1112-7. View Abstract
  204. Interventional catheter procedures used in congenital heart disease. Cardiol Clin. 1993 Nov; 11(4):569-87. View Abstract
  205. Inhaled nitric oxide in chronic obstructive lung disease. Lancet. 1993 Jan 30; 341(8840):307-8. View Abstract
  206. Transcatheter closure of cardiac defects. Adv Pediatr. 1993; 40:247-71. View Abstract

Contact Michael Landzberg

Print Profile